Loading…
XOMA Royalty Corporation is projected to rise to $68.56 by 2027, a +64% move from its current price of $41.74. XOMA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $41.12 | $41.79 | $42.48 | +0.12% |
| May 30 | $40.89 | $41.84 | $42.82 | +0.25% |
| May 31 | $40.73 | $41.89 | $43.09 | +0.37% |
| Jun 1 | $40.60 | $41.95 | $43.33 | +0.49% |
| Jun 2 | $40.50 | $42.00 | $43.55 | +0.62% |
| Jun 3 | $40.41 | $42.05 | $43.76 | +0.74% |
| Jun 4 | $40.33 | $42.10 | $43.95 | +0.86% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $40.33 | $42.10 | $43.95 | +0.86% |
| Week 2 | $39.96 | $42.47 | $45.13 | +1.74% |
| Week 3 | $39.76 | $42.83 | $46.15 | +2.62% |
| Week 4 | $39.64 | $43.20 | $47.09 | +3.51% |
| Week 5 | $39.58 | $43.58 | $47.98 | +4.40% |
| Week 6 | $39.56 | $43.95 | $48.84 | +5.30% |
| Week 7 | $39.56 | $44.33 | $49.68 | +6.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
XOMA Royalty Corporation operates as a biotech royalty aggregator with a portfolio of economic rights to future milestone and royalty payments tied to commercial products and pre-commercial therapeutic candidates. It focuses on early to mid-stage clinical assets, primarily in Phase 1 and 2, with commercial sales potential that are licensed to sponsors or developers; it also acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets.
The company has assets across the United States, Switzerland, the Asia Pacific region, and Australia. It was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Royalty Corporation (XOMA) is a healthcare asset with a current price of $41.65 and a market cap of $522.33M. It holds a position in the market with a rank of 3012.
The price outlook is captured in a year-by-year forecast that shows a neutral stance in 2026 (min $22.89, avg $41.65, max $65.27; ROI 0; sentiment NEUTRAL) and a bullish trajectory from 2027 onward, with escalating averages and ROI through to 2050 (2027 avg $69.06; 2028 avg $86.10; 2029 avg $101.56; 2030 avg $113.71; 2040 avg $449.94; 2050 avg $1,023.84).
These figures illustrate a long-term upward path for the asset, with substantial upside implied by the 2030, 2040, and 2050 forecasts.
A major floor 45.2% below — a decisive break under it would weaken the trend.
The nearest floor, 9.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.6% away) — a breakout level to watch.
A major ceiling 7.0% above — clearing it would confirm fresh momentum.
Key XOMA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XOMA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.78 | Sell | $41.74 | Buy |
| MA 10 | $41.76 | Sell | $41.68 | Buy |
| MA 20 | $41.58 | Buy | $41.09 | Buy |
| MA 50 | $37.45 | Buy | $37.88 | Buy |
| MA 100 | $31.83 | Buy | $34.67 | Buy |
| MA 200 | $32.46 | Buy | $32.16 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.31 | Neutral |
| Stoch RSI (14) | 8.70 | Buy |
| CCI (20) | 43.19 | Neutral |
| Williams %R (14) | -36.62 | Info |
| MACD (12,26,9) | -0.34 | Sell |
| ROC (12) | -0.36 | Sell |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 63.38 | Neutral |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 1.19 | Buy |
| Ultimate (7,14,28) | 51.60 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 41.73 | Buy |
| ADX (14) | 37.48 | Buy |
| ATR (14) | 0.36 | Info |
The 30-day technical picture is bullish. RSI14 is 60, and the moving averages show SMA50 at $36.84 and SMA200 at $32.30.
Near-term support is marked at $37.89 with resistance at $42.00. The stock has traded in a 30-day range of $37.16 to $46.68, highlighting a defined high and low boundary over the period. Annualized volatility stands at 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.89 | $41.74 | $64.98 | 0% | Neutral | |
| $56.01 | $68.56 | $87.85 | +64% | Bullish | |
| $69.17 | $86.22 | $113.35 | +107% | Bullish | |
| $79.92 | $101.12 | $135.72 | +142% | Bullish | |
| $88.08 | $112.93 | $154.25 | +171% | Bullish | |
| $102.01 | $132.37 | $183.62 | +217% | Bullish | |
| $115.93 | $152.12 | $213.98 | +264% | Bullish | |
| $144.42 | $191.49 | $272.82 | +359% | Bullish | |
| $175.69 | $235.25 | $339.12 | +464% | Bullish | |
| $185.73 | $251.03 | $365.88 | +501% | Bullish | |
| $312.87 | $440.99 | $673.35 | +957% | Bullish | |
| $664.58 | $1,004.46 | $1,643.57 | +23.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $22.89 | $41.74 | $49.07 | +0.00% |
| June 2026 | $38.18 | $44.53 | $52.96 | +6.69% |
| July 2026 | $39.80 | $46.70 | $56.06 | +4.86% |
| August 2026 | $40.34 | $47.54 | $57.49 | +1.81% |
| September 2026 | $41.76 | $49.40 | $60.08 | +3.90% |
| October 2026 | $43.74 | $51.92 | $63.49 | +5.11% |
| November 2026 | $44.11 | $52.52 | $64.53 | +1.16% |
| December 2026 | $44.10 | $52.65 | $64.98 | +0.26% |
Click any year to see its month-by-month XOMA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
XOMA Royalty Corporation's 2026 outlook centres on $41.74, within a $22.89 to $64.98 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, XOMA could reach as high as $87.85, with a base case around $68.56 and support toward $56.01 — roughly +64% from $41.74. Buyers look set to stay in control over this stretch.
Expect XOMA to range from $69.17 to $113.35 through 2028. The $86.22 average target implies a +107% move from current prices. That is up +26% on the projected 2027 average. Momentum favours further upside here.
The XOMA price prediction for 2029 points to an average of $101.12 (low $79.92, high $135.72) — a potential gain of +142% on today's $41.74. Buyers look set to stay in control over this stretch.
In 2030, XOMA is projected to trade between $88.08 and $154.25, averaging $112.93 — a potential gain of +171% from today's $41.74. That is up +12% on the projected 2029 average. Momentum favours further upside here.
XOMA Royalty Corporation's 2031 outlook centres on $132.37, within a $102.01 to $183.62 range. That is up +17% on the projected 2030 average. That marks a +217% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, XOMA could reach as high as $213.98, with a base case around $152.12 and support toward $115.93 — roughly +264% from $41.74. Momentum favours further upside here.
Expect XOMA to range from $144.42 to $272.82 through 2033. The $191.49 average target implies a +359% move from current prices. That is up +26% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The XOMA price prediction for 2034 points to an average of $235.25 (low $175.69, high $339.12) — a potential gain of +464% on today's $41.74. Momentum favours further upside here.
In 2035, XOMA is projected to trade between $185.73 and $365.88, averaging $251.03 — a potential gain of +501% from today's $41.74. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
XOMA Royalty Corporation's 2040 outlook centres on $440.99, within a $312.87 to $673.35 range. That is up +76% on the projected 2035 average. That marks a +957% change versus current levels. Momentum favours further upside here.
By 2050, XOMA could reach as high as $1,643.57, with a base case around $1,004.46 and support toward $664.58 — roughly +23.1x from $41.74. Buyers look set to stay in control over this stretch.
Investing $1,000 in XOMA today (≈ 23.957834 XOMA) could be worth
$24,064.7
+$23,064.7 (+2306%) by 2050 · US Dollar
Based on the average projected XOMA price of $1,004.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XOMAwould be worth at today's price.
$1,000 invested in XOMA on May 27, 2025 (≈ 40.128411 XOMA) would be worth
$1,674.96
+$674.96 (+67.5%) today · 1.67× · US Dollar
Based on a XOMA entry price of $24.92 vs. today's $41.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $41.98 | $994.28 | -0.6% |
| 1 month ago | $41.97 | $994.52 | -0.5% |
| 3 months ago | $26.76 | $1,559.79 | +56.0% |
| 6 months ago | $32.13 | $1,299.1 | +29.9% |
| 1 year ago | $24.92 | $1,674.96 | +67.5% |
| All time (5.0y) ago | $30.4 | $1,373.03 | +37.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XOMA forecast.
Our base-case forecast reaches $83.00 around 2028.
Implied market cap at $83.00: $1.04B
The multi-year forecast paints a bullish arc after 2026, with steadily rising averages and upside potential. In 2027 the avg is $69.06 with min $56.40 and max $88.52, and a bullish sentiment; the ROI is 65.8%. In 2030 the avg is $113.71, with min $88.67 and max $155.35, and a bullish sentiment; the ROI is 173.
In 2040 the avg climbs to $449.94 (min $319.19, max $687.09) with a bullish sentiment and a ROI of 980.3. By 2050 the avg reaches $1,023.84 (min $677.35, max $1,675.42) and the ROI is 2358.2, with continued bullish sentiment.
These numbers are estimates, not guarantees, and reflect the forecasted path of the asset across years as provided.
Tap a question to reveal the answer.
Avg $113.71; min $88.67; max $155.35; ROI 173; sentiment BULLISH.
The 2026 forecast is neutral (avg $41.65; min $22.89; max $65.27; ROI 0). From 2027 onward the forecast is bullish with rising averages and ROI (e.g., 2027 avg $69.06; ROI 65.8; 2028 avg $86.10; ROI 106.7).
Avg $449.94; min $319.19; max $687.09; ROI 980.3; sentiment BULLISH.
Avg $1,023.84; min $677.35; max $1,675.42; ROI 2358.2; sentiment BULLISH.
Current price $41.65; market cap $522.33M; rank 3012.
XOMA Royalty Corporation Community Discussion
0Share your XOMA Royalty Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.